Alyeska Investment Group
TTHI

Alyeska Investment Group’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Alyeska Investment Group’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-38,285
Closed -$56K – 596
2016
Q2 		$56K Sell
38,285
-254,067
-87% -$220K ﹤0.01% 419
2016
Q1 		$374K Buy
292,352
+9,037
+3% +$10.4K ﹤0.01% 368
2015
Q4 		$544K Buy
283,315
+11,551
+4% +$21.9K 0.01% 354
2015
Q3 		$486K Buy
271,764
+74,335
+38% +$158K 0.01% 427
2015
Q2 		$415K Sell
197,429
-32,571
-14% -$228K ﹤0.01% 460
2015
Q1 		$1.57M Buy
+230,000
New +$1.59M 0.02% 394

Other funds holding TTHI

HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Alyeska Investment Group's TTHI Position: Q3 2016 in Review

Alyeska Investment Group sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q3 2016, closing a stake of 38,285 shares — an estimated $56K sold.

Alyeska Investment Group first reported a position in TTHI in Q1 2015 and held it in 6 quarters. The position peaked at $1.57M in Q1 2015. 2 funds tracked by Wall St. Rank hold TTHI as of Q3 2016.

  • Alyeska Investment Group reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q3 2016 after selling out during the quarter.
  • Alyeska Investment Group sold 38,285 TRANSITION THERAPEUTICS INC (CANADA) shares in Q3 2016, an estimated $56K.
  • Alyeska Investment Group first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q1 2015 and held it in 6 quarters.
  • Alyeska Investment Group's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $1.57M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q3 2016.

Based on Alyeska Investment Group's 13F filing for Q3 2016, filed 14 Nov 2016.